Endonovo Therapeutics Inc (PK) (ENDV) Actualités

Form SEC STAFF ACTION - SEC Staff Action: ORDER

Form 15-12G - Securities registration termination [Section 12(g)]

Form 8-K - Current report

Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]

Form 8-K - Current report

Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB

Form 8-K - Current report

Form 1-A/A - Offering Statement [Regulation A]: [Amend]

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Amended Registration a Offering Under the Securities Act of 1933 (1-a/a)

Form 1-A Issuer Information UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 1-A...

Notification That Quarterly Report Will Be Submitted Late (nt 10-q)

      UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549  ...

Annual Report (10-k)

0001528172 false FY

Notification That Annual Report Will Be Submitted Late (nt 10-k)

      UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549  ...

Current Report Filing (8-k)

0001528172 false 0001528172 2023-03-28 2023-03-28 iso4217:USD xbrli:shares...

Notification That Quarterly Report Will Be Submitted Late (nt 10-q)

      UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549  ...